Tag Archives: TTM

Top 10 Heal Care Stocks To Buy For 2019

Shares of ArQule (ARQL) have risen by over 550% since I published my initial article advising readers that there were ¨several ways to win here¨. Shares have increased by around 290% since my latest update piece was published in which I stated that the stock was presenting investors with an enticing risk/reward setup into AACR.

Chart

Figure 1: ARQL daily advanced chart (Source: Finviz)

Figure 2: ARQL 15-minute chart (Source: Finviz)

Top 10 Heal Care Stocks To Buy For 2019: Honeywell International Inc.(HON)

Advisors’ Opinion:

  • [By Paul Ausick]

    Honeywell International Inc. (NYSE: HON) reported fourth-quarter and full-year 2017 results before markets opened Friday. For the quarter, the conglomerate posted adjusted diluted earnings per share (EPS) of $1.85 on revenues of $10.84 billion. In the same period a year ago, the company reported EPS of $1.74 on revenues of $9.99 billion. Fourth-quarter results also compare to consensus estimates for EPS of $1.84 and $10.75 billion in revenues.

  • [By Garrett Baldwin]

    Well, Money Morning Special Situation Strategist Tim Melvin has broken these secrets out of the vault of the Smart Money managers. And he’s sharing the Max Wealth secrets for free right here.

    Two Stocks to Watch Today: XOM, DB
    Shares of Exxon Mobil Corp. (NYSE: XOM) jumped more than 2.6% in pre-market hours after the energy giant reported earnings before the bell. The oil major reported earnings per share of $1.41, easily topping Wall Street forecasts of $1.08. Its $7.2 billion in quarterly profits were a 72% jump from the same period last year. However, the firm did fall a bit short on the revenue front. Investors liked the news that Exxon plans to restructure its upstream business to reduce costs and bolster operating cash flow by 2025. On the European front, shares of Deutsche Bank (NYSE: DB) were off another 3.72% after the German banking giant reported earnings. The embattled financial institution reported its first annual profit since 2014. However, broader uncertainty remains from investors. On Friday, look for earnings reports from Chevron Corp. (NYSE: CVX), Cigna Holding Co. (NYSE: CI), Weatherford International Plc. (NYSE: WFT), Roper Technologies Inc. (NYSE: ROP), Merck & Co. Inc. (NYSE: MRK), Honeywell International Inc. (NYSE: HON), and Johnson Controls International Plc. (NYSE: JCI).
    These 3 Stocks Are the Key to 2019’s Greatest Profits

    The 2018 midterm election was a turning point for the cannabis industry.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s rankings:

    Can Aerospace Strength Drive Honeywell (HON) in Q1 Earnings? (finance.yahoo.com) Could Honeywell Beat Analysts’ Earnings Estimates Again? (marketrealist.com) OJets selects Honeywell for in-flight connectivity (ainonline.com) Analysts’ Views on Honeywell, Pre-1Q18 Earnings Release (marketrealist.com) Honeywell (HON) Stock Rating Reaffirmed by Cowen (americanbankingnews.com)

    A number of equities research analysts have weighed in on the company. Zacks Investment Research raised Honeywell from a “hold” rating to a “buy” rating and set a $160.00 target price for the company in a research report on Tuesday, April 3rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $165.00 target price on shares of Honeywell in a research report on Friday, February 16th. Cowen reaffirmed a “buy” rating and set a $168.00 target price on shares of Honeywell in a research report on Monday, January 22nd. Robert W. Baird reaffirmed a “buy” rating and set a $187.00 target price on shares of Honeywell in a research report on Friday, January 26th. Finally, Bank of America lifted their target price on Honeywell from $117.12 to $168.00 and gave the company a “buy” rating in a research report on Friday, January 26th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $166.07.

  • [By Ethan Ryder]

    CIBC World Markets Inc. lessened its position in Honeywell International Inc. (NYSE:HON) by 5.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 106,160 shares of the conglomerate’s stock after selling 6,435 shares during the period. CIBC World Markets Inc.’s holdings in Honeywell International were worth $15,292,000 at the end of the most recent reporting period.

  • [By Chris Lange]

    And Honeywell International PLC (NYSE: HON) will report its fourth-quarter results on Friday. The analysts’ consensus estimates are EPS of $1.84 and $10.75 billion in revenue. The stock was last seen at $158.69 a share. The consensus price target is $166.81, and the 52-week range is $116.98 to $159.85.

Top 10 Heal Care Stocks To Buy For 2019: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was the target of unusually large options trading activity on Wednesday. Stock investors acquired 9,610 call options on the company. This represents an increase of 5,123% compared to the typical daily volume of 184 call options.

  • [By Jon C. Ogg]

    Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid treatment has become an elusive target. And it’s too bad when you consider how many people have become addicted to opioids in America.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Pacira Pharmaceuticals (PCRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Pacira Pharmaceuticals Inc (NASDAQ:PCRX) has been given an average rating of “Hold” by the twenty-four ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and ten have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $46.65.

Top 10 Heal Care Stocks To Buy For 2019: Tata Motors Ltd(TTM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about Tata Motors (NYSE:TTM) have trended somewhat positive on Monday, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tata Motors earned a news impact score of 0.23 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.2298115164749 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Shares of Tata Motors Limited (NYSE:TTM) have been assigned an average rating of “Hold” from the eight brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $30.00.

  • [By John Rosevear]

    First up is the I-Pace, the crossover SUV from Tata Motors’ (NYSE:TTM) Jaguar luxury brand. The I-Pace has already begun shipping in Europe, but it won’t arrive in the United States until the second half of 2018.

  • [By John Rosevear]

    Shares of Indian automaker Tata Motors (NYSE:TTM) fell sharply on Tuesday morning, after the company announced that its important Jaguar Land Rover subsidiary will cut production after a sharp drop in sales in China. 

  • [By Paul Ausick]

    Tata Motors Ltd. (NYSE: TTM) fell by about 2% Monday to post a new 52-week low of $23.82 after closing at $24.30 on Friday. The 52-week high is $37.62. Volume of about 3.6 million was more more than double the daily average of about 1.5 million. The company had no specific news.

  • [By Dan Caplinger]

    U.S. stocks have enjoyed years of strong gains, but the situation hasn’t been as rosy for many companies that do business across the globe. India’s Tata Motors (NYSE:TTM), which owns key car brands such as Jaguar and Land Rover, gave investors an extremely tough financial report that led to two days’ worth of severe share-price declines. Yet closer to home, Motorola Solutions (NYSE:MSI) has made a name for itself with its services to enterprise and government customers.

Top 10 Heal Care Stocks To Buy For 2019: First Trust Water ETF (FIW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Wells Fargo & Company MN decreased its stake in shares of First Trust Water ETF (NYSEARCA:FIW) by 11.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,540 shares of the company’s stock after selling 36,231 shares during the quarter. Wells Fargo & Company MN’s holdings in First Trust Water ETF were worth $13,256,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    First Trust ISE Water Index Fund (NYSEARCA:FIW) declared a quarterly dividend on Thursday, June 21st, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be paid a dividend of 0.0861 per share on Friday, June 29th. This represents a $0.34 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Thursday, June 21st. This is a positive change from First Trust ISE Water Index Fund’s previous quarterly dividend of $0.06.

  • [By Logan Wallace]

    Raymond James & Associates increased its position in First Trust Water ETF (NYSEARCA:FIW) by 45.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 61,717 shares of the company’s stock after buying an additional 19,152 shares during the period. Raymond James & Associates’ holdings in First Trust Water ETF were worth $2,969,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Buy For 2019: FRP Holdings, Inc.(FRPH)

Advisors’ Opinion:

  • [By Max Byerly]

    FRP Holdings Inc (NASDAQ:FRPH) VP John D. Milton, Jr. sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 14th. The stock was sold at an average price of $59.07, for a total value of $177,210.00. Following the transaction, the vice president now owns 632 shares in the company, valued at approximately $37,332.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

  • [By Joseph Griffin]

    FRP (NASDAQ:FRPH) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

  • [By Motley Fool Transcribers]

    FRP Holdings Inc  (NASDAQ:FRPH)Q4 2018 Earnings Conference CallMarch 07, 2019, 1:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    FRP (NASDAQ:FRPH) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.

Top 10 Heal Care Stocks To Buy For 2019: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Intrepid Potash (NYSE:IPI) are falling, down 20.8% as of 12:02 p.m. EDT, after the company announced second-quarter 2018 earnings. The fertilizer producer actually turned in a solid performance compared to the year-ago period for all three of its major business activities — potash, Trio, and water — and more than doubled operating cash flow. Furthermore, management expects the business to continue improving in future periods. 

  • [By Lisa Levin]

    Wednesday morning, the materials shares rose 0.83 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), up 8 percent, and Braskem S.A. (NYSE: BAK) up 6 percent.

  • [By Ethan Ryder]

    Hi-Crush Partners (NYSE: HCLP) and Intrepid Potash (NYSE:IPI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation.

  • [By Motley Fool Transcribers]

    Intrepid Potash Inc  (NYSE:IPI)Q4 2018 Earnings Conference CallMarch 12, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Maxx Chatsko]

    While the global fertilizer industry continues to struggle with imbalanced markets, efforts hyper-focused on operational efficiency have begun to pay off for several producers. Investors can count small cap Intrepid Potash (NYSE:IPI) among them.

  • [By Maxx Chatsko]

    Shares of Intrepid Potash (NYSE:IPI) rose as much as 16% today as investors poured back into the stock following a more than 20% drop yesterday, when the fertilizer producer reported second-quarter and first-half 2018 earnings results. While the results were actually pretty good, and demonstrated that the company is executing against its strategy to deliver profitable growth, Wall Street analysts panicked over a miss on the bottom line.

Top 10 Heal Care Stocks To Buy For 2019: Allison Transmission Holdings, Inc.(ALSN)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Allison Transmission Holdings Inc  (NYSE:ALSN)Q4 2018 Earnings Conference CallFeb. 26, 2019, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) and ATC Venture Group (OTCMKTS:ATCV) are both auto/tires/trucks companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

  • [By Stephan Byrd]

    Allison Transmission (NYSE:ALSN) – Investment analysts at Oppenheimer increased their FY2018 earnings per share (EPS) estimates for Allison Transmission in a research note issued on Monday, April 30th. Oppenheimer analyst I. Zaffino now expects that the auto parts company will post earnings of $3.79 per share for the year, up from their previous forecast of $3.32. Oppenheimer also issued estimates for Allison Transmission’s FY2019 earnings at $4.16 EPS.

Top 10 Heal Care Stocks To Buy For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) jumped 20.9% in August, according to data provided by S&P Global Market Intelligence as investors in the biotech become more comfortable with the potential of Tavalisse, Rigel’s recently approved drug for chronic immune thrombocytopenia, which is characterized by low blood platelet levels.

  • [By Maxx Chatsko]

    Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) climbed over 17% today after the company announced second-quarter and first-half 2018 earnings results. The pharma company reported $1.8 million in net product sales of Tavalisse, the portfolio’s first approved product, during the most recent quarter. That may not seem like much, but not when you consider that the chronic immune thrombocytopenia (ITP) treatment only launched on May 29. 

  • [By Trey Thoelcke]

    Here too, the low price makes this stock an attractive target. Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) is engaged in the discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

  • [By Cory Renauer]

    Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.

    Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
    Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
    Vital Therapies, Inc. (NASDAQ:VTL) Cantor Fitzgerald $18 142%
    Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Citigroup $8.50

    156%

  • [By Logan Wallace]

    Rock Springs Capital Management LP raised its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 4.0% in the first quarter, Holdings Channel reports. The fund owned 2,575,000 shares of the biotechnology company’s stock after buying an additional 100,000 shares during the period. Rock Springs Capital Management LP’s holdings in Rigel Pharmaceuticals were worth $9,116,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Buy For 2019: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Most people who think about retail focus on the hot products that are always in demand. Yet at the other end of the spectrum are the products that perhaps were once needed but now find themselves either out of fashion or no longer necessary for the typical customer. That’s where Liquidity Services (NASDAQ:LQDT) comes in, offering a way for government and private sector clients to dispose of surplus inventory effectively and efficiently. That niche has challenges of its own, but the company has been making moves to build its business back up and hopefully return to profitability.

  • [By Joseph Griffin]

    Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Heal Care Stocks To Buy For 2019: SunCoke Energy Partners, L.P.(SXCP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday.
    SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results.
    Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance.
    New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results.
    Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash.
    China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday.
    Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results.
    eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results.
    Southw

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SunCoke Energy Partners (SXCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Hot Low Price Stocks To Buy For 2019

Five semiconductor companies are in a prime position to benefit from the rollout of 5G, the fifth generation of wireless communication that telecom companies are racing to implement, CNBC’s Jim Cramer said Wednesday.

“If you’re a semiconductor company with 5G exposure, this is your moment,” he said after Skyworks Solutions, an Apple supplier that fits that description, surged over 12 percent intraday after delivering its quarterly earnings results.

Skyworks’ surge was so strong that it lifted shares of other chipmakers involved in 5G, including Intel, Qualcomm, Broadcom, and Xilinx, all of which stand to benefit from the rise of 5G, Cramer said on “Mad Money.”

And while he preferred the stock of Skyworks to its peers because of its low price tag and the company’s focus on 5G, he said investors “can make the case for all five.”

Hot Low Price Stocks To Buy For 2019: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Joseph Griffin]

    Boston Partners purchased a new stake in Sandstorm Gold (NYSEAMERICAN:SAND) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 463,325 shares of the mining company’s stock, valued at approximately $2,205,000. Boston Partners owned about 0.25% of Sandstorm Gold as of its most recent filing with the Securities and Exchange Commission.

Hot Low Price Stocks To Buy For 2019: PacWest Bancorp(PACW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PacWest Bancorp (NASDAQ:PACW) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    PagSeguro Digital (NYSE:PAGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on PacWest Bancorp (PACW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    PacWest Bancorp (NASDAQ:PACW) – Stock analysts at Wedbush reduced their Q1 2019 earnings per share estimates for shares of PacWest Bancorp in a research report issued on Wednesday, September 12th. Wedbush analyst D. Chiaverini now forecasts that the financial services provider will earn $0.89 per share for the quarter, down from their prior estimate of $0.90. Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for PacWest Bancorp’s Q1 2020 earnings at $0.98 EPS and Q2 2020 earnings at $1.02 EPS.

  • [By Ethan Ryder]

    Eagle Boston Investment Management Inc. raised its holdings in PacWest Bancorp (NASDAQ:PACW) by 4.3% during the second quarter, HoldingsChannel.com reports. The firm owned 216,438 shares of the financial services provider’s stock after buying an additional 8,918 shares during the period. Eagle Boston Investment Management Inc.’s holdings in PacWest Bancorp were worth $10,696,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on PacWest Bancorp (PACW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    ValuEngine upgraded shares of PacWest Bancorp (NASDAQ:PACW) from a sell rating to a hold rating in a research report report published on Wednesday morning.

Hot Low Price Stocks To Buy For 2019: Synacor, Inc.(SYNC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Syncona Ltd (LON:SYNC) announced a dividend on Thursday, June 14th, Upcoming.Co.Uk reports. Investors of record on Thursday, June 21st will be paid a dividend of GBX 2.30 ($0.03) per share on Monday, July 30th. This represents a yield of 1.02%. The ex-dividend date is Thursday, June 21st. The official announcement can be seen at this link.

  • [By Stephan Byrd]

    Media coverage about Synacor (NASDAQ:SYNC) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Synacor earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned news coverage about the information services provider an impact score of 47.6409011491603 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Synacor (SYNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    HealthStream (NASDAQ: SYNC) and Synacor (NASDAQ:SYNC) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability.

  • [By WWW.GURUFOCUS.COM]

    For the details of INTEL CORP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=INTEL+CORP

    These are the top 5 holdings of INTEL CORPCloudera Inc (CLDR) – 26,065,827 shares, 92.26% of the total portfolio. Borqs Technologies Inc (BRQS) – 3,799,172 shares, 5.42% of the total portfolio. ForeScout Technologies Inc (FSCT) – 257,756 shares, 1.37% of the total portfolio. Aquantia Corp (AQ) – 161,492 shares, 0.42% of the total portfolio. Synacor Inc (SYNC) – 866,884 shares, 0.23% of the total portfolio. New

Hot Low Price Stocks To Buy For 2019: Tata Motors Ltd(TTM)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) autonomous car division, Waymo, recently signed a contract to add Jaguar’s first all-electric car to its fleet of self-driving vehicles. For the Google parent company, the deal will be a blip on its path to driving automation, albeit an exciting one. For shareholders of Jaguar parent Tata Motors (NYSE:TTM), it’s an early sign the new vehicle will be a winner for the automaker.

  • [By Money Morning Staff Reports]

    Take Tata Motors Ltd. (NYSE: TTM) for example. The Indian carmaker has nearly tripled its profits since 2010 and has grown sales for nine of the last 10 years. Plus, it sports a price/earnings ratio of just 12.6, about half of the S&P 500 average, so you’re not overpaying to access those profits.

  • [By John Rosevear]

    First up is the I-Pace, the crossover SUV from Tata Motors’ (NYSE:TTM) Jaguar luxury brand. The I-Pace has already begun shipping in Europe, but it won’t arrive in the United States until the second half of 2018.

  • [By Logan Wallace]

    Shares of Tata Motors Limited (NYSE:TTM) have been assigned an average rating of “Hold” from the eight brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $30.00.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Paul Ausick]

    Tata Motors Ltd. (NYSE: TTM) fell by about 2% Monday to post a new 52-week low of $23.82 after closing at $24.30 on Friday. The 52-week high is $37.62. Volume of about 3.6 million was more more than double the daily average of about 1.5 million. The company had no specific news.

Hot Low Price Stocks To Buy For 2019: Insignia Systems, Inc.(ISIG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Insignia Systems, Inc. (NASDAQ:ISIG) major shareholder Air T. Inc acquired 16,879 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were bought at an average price of $1.81 per share, for a total transaction of $30,550.99. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Hot Low Price Stocks To Buy For 2019: Impax Laboratories, Inc.(IPXL)

Advisors’ Opinion:

  • [By Max Byerly]

    News articles about Impax Laboratories (NASDAQ:IPXL) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Impax Laboratories earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the specialty pharmaceutical company an impact score of 43.4189030940397 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

2018 IPO Prospects: Lyft Appears To Be Changing Gears To List

According to a Goldman Sachs report, the global ride-hailing market is expected to grow from $36 billion in 2017 to $285 billion by 2030. The average number of ride-hailing trips a day globally are expected to grow from 15 million in 2017 to 97 million by 2030. The ride-hailing companies are expected to charge an average 23% commission on the gross sales, translating to net revenues of $65 billion by 2030 for the industry. While Uber (Private:UBER) continues to remain the market leader in the industry, its recent troubles have helped drive usage for competitors, such as Lyft (Private:LYFT), to higher levels. Lyft may even beat Uber to an IPO listing this year.

Lyft’s Growth

Lyft, still largely focused in the US, has grown significantly during the past year. According to its Co-Founder and President John Zimmer, Lyft more than doubled the 162.6 million rides it provided in 2016. It is now available in all the 50 US states. Last year, Lyft also made its first international presence when it began operating its service in Toronto, Canada. Lyft has clearly benefited from all the turmoil at Uber. Here is an interesting infographic, courtesy recode, that shows how Lyft made big advances in San Francisco and New York, when compared with Uber.

Besides market expansion for the ride-sharing service, Lyft also has been actively focused on the autonomous driving market. Last year, Lyft entered into several partnerships with automakers such as Ford (NYSE:F), Tata Motors’ (NYSE:TTM) Jaguar Land Rover, and General Motors (NYSE:GM) to test self-driving vehicles in the network. It launched an open platform that is designed to give these automakers and tech companies the ability to work on self-driving cars that will be accessible to its ride-sharing network.

It officially launched the service last month in Boston when it sent autonomous vehicles, developed by the startup NuTonomy, to pick passengers in Boston’s Seaport district. The riders are randomly paired with one of NuTonomy’s self-driving cars when they use the Lyft app in the Seaport area. The car comes with a driver behind the wheel who is ready to take control, when needed. The partnership will help establish user confidence in the driverless car model along with helping improve the performance through feedback from pilot participants. Later this month, Lyft will also launch a similar service for the Consumer Electronics Show happening in Las Vegas. Attendees will be able to ride the autonomous cars on 20 pre-defined routes and destinations. The service will be provided in collaboration with Aptiv, which will work on the automated driving vehicles, while Lyft will take on the dispatch.

Lyft is not the only ride-sharing service to offer autonomous cars. Uber already has the service running in Pittsburgh and Phoenix. But Uber is being sued over its autonomous driving technology by Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) and has also been involved in a few traffic incidents in these markets.

Lyft’s Financials

Lyft’s user growth has translated to higher revenues in 2017. While the company still does not disclose detailed financials, recent reports revealed that its gross revenues grew from $150 million in the first half of 2016 to $483 million for the first half of 2017. During the same period, losses have reduced from $283 million to $206 million. During the same period, Uber is estimated to have earned $3 billion in revenues with losses of $2 billion.

Lyft has been venture funded so far and has raised $4.2 billion from investors including Fidelity Management & Research Company, Ontario Teachers’ Pension Plan, Capital G, Icahn Enterprises, Rakuten, Coatue Management, Andreessen Horowitz, Founders Fund, Mayfield Fund, FLOODGATE, K9 Ventures, and fbFund. Its last funding round was held in December 2017 , when it raised $500 million at a valuation of $11.5 billion from investors including Fidelity Management & Research Company and Ontario Teachers’ Pension Plan. Valuation has grown steadily from $10 billion back in October 2017 and $7.5 billion in April 2017. It is still a far cry from Uber’s valuation of $68 billion.

Many believe that Lyft is very close to going public as it is about to select its IPO advisors to help it list. It also added Kristina Omari as its first-ever vice president of corporate development and customer relations – a move expected to be part of the IPO initiative.

About this article:ExpandTagged: Investing Ideas, IPO Analysis, TechnologyWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

iRobot: Why The Roomba Maker Can’t Get Traction

iRobot (NASDAQ: IRBT) shareholders have been on a wild ride this past year. The stock began the year in the high $50s and proceded to almost double, topping at $109 in July after Q2 earnings trounced estimates. Since then, the stock has experienced huge big gyrations in both directions as both bulls and bears pushed their case regarding the future of the stock. As the year is coming to a close, the bears seem to be having their way as the stock is currently sitting at $66 per share, not far from where it started the year.

Chart
IRBT data by YCharts

As I see it, there are three basic reasons why the swings have been unusually pronounced.

High Short Interest Emotional Investment/Confirmation Bias-Many authors who have written about iRobot have written numerous articles with subsequent articles often serving the purpose of strengthening or justifying their previous stance. We are all human and confirmation bias is a powerful force. Even the great investors(think Warren Buffett and Coca-Cola) are affected by this powerful force at times. One-trick pony-While iRobot technically has three product lines, the Q3 report showed 89.8% of its revenue coming from the robotic vacuum cleaner segment. That means two things. First, when there is only one product involved, any news, good or bad, is magnified, leading to magnified stock movements. Secondly, because at least for the time being, Roomba essentially is iRobot, I will be focusing on the robotic vacuum cleaner segment and we develop an investing thesis.

SOURCE: IROBOT THIRD QUARTER REVENUE BREAKDOWN IN MILLIONS

A lot of the noise surrounding iRobot seems to be based more on emotions than numerical projections. The bears have won the last round. Let’s dig into the details and examine whether the recent stock price is justified or whether this maker of home robots deserves a better fate from the market.

ROOMBA ROBOTIC VACUUM CLEANER

SOURCE: IROBOT

The Bull Case: A Rapidly Growing Market, Dominant Market Share, and a Trusted Brand

There is no doubt that iRobot’s main product is positioned in a rapidly growing market. The question is just how rapid that market growth will be. Estimates, expectations, and hopes vary wildly. Sandler Research estimates that the robotic vacuum cleaner market will experience 15.3% annualized growth through 2020. Technovia has a similar forecast. iRobot is looking at things through a different lens. iRobot is targeting a market they refer to as immediately addressable. The immediately addressable market, according to management, consists of 27 million U.S. households and would represent 300% market growth. We know there will be growth. The key will be whether the next two years bring 30% market growth as Sandler and Technovia predict, or if iRobot will succeed in addressing the much larger market depicted below.

SOURCE: IROBOT

Right now, iRobot has an absolutely dominant market share in the robotic vacuum cleaner industry. At the end of 2016, the company commanded 88% of the market in North America and 64% of the market worldwide.

Maintaining that market share will not be easy but iRobot has an impressive patent portfolio and believes those patents are potent in fending off the competition. On four separate recent occasions, CEO Colin Angle has commented on the importance of its intellectual property. iRobot recently won a patent dispute and has vowed to vigorously defend its patent portfolio. The clearest indication of how management feels is illustrated in this comment Angle made in an interview with Reuters:

The patents are a huge part of our competitive moat. It is getting really hard not to step on our intellectual property.

While iRobot technically was not the first company to bring a robotic vacuum cleaner to market, there is no doubt that the Roomba was the first cleaner to gain widespread name recognition. Therefore, Roomba enjoys the perks that come with “first mover” status. That is important since research has shown that when all other things are equal, buyers tend to gravitate toward a known entity.

Other Positives to Note:

Management recently raised full-year guidance. Gross margin actually increased over the last three years. An Aging population could be a tailwind. Estimates for 33% revenue growth in 2017 blow away Technovia and Sandler Research’s expectations for market growth. The acquisitions of two distributors should provide some margin protection. Lots of cash and no debt. Four consecutive earnings beats.

The Bear Case: Commoditization and Competition Coming on Like Gangbusters

With the recent performance and all the positives listed above, it is reasonable to wonder why, as the title of this article states, the company’s stock cannot get any traction. I will say the battle between the bulls and the bears is interesting. I would estimate about 85% of all the articles I have read in the last 6 months have been bullish. Yet analysts have become more bearish as evidenced by the four downgrades and absolutely no upgrades since mid-March. And while analysts have turned more bearish, there is no doubt that the biggest and most vocal bear of all is Spruce Point Capital Management.

Before I get into the specifics of the bear case, here is a little history of the Spruce Point/iRobot relationship. Spruce Point has been dogging iRobot for three and a half years, issuing strong sell recommendations all along the way. Spruce Point is currently puffing its chest with a lot of “I told you so” type comments as iRobot’s stock price has almost been cut in half since July. While Spruce Point does have some valid points, it is also worth noting that Spruce Point began publishing its hit pieces in May of 2014. Since the first hit piece, even with the recent drop, iRobot’s stock has more than doubled the return of the S&P. Enough on Spruce Point, however, let’s dig into the bearish arguments behind the drop and see if they have any staying power.

Chart
IRBT data by YCharts

The first bear argument is that iRobot’s only meaningful revenue source, the Roomba, is becoming a commoditized home appliance. Let’s explore.

Below, we have an image from iRobot’s investor presentation showing its expectations with regard to new product growth. Right now, the Roomba is in the “explosive growth” stage. That is hard to deny. iRobot acknowledges that any products with explosive growth will at some point transition into the “commoditization stage”. The big question is the time frame. While management believes growth will accelerate for the foreseeable future, the bears feel commoditization is happening as we speak.

A quick search on Amazon.com (NASDAQ: AMZN) gives us some good information. A quick search in the home and kitchen area for robotic vacuums under $200 shows over 1200 choices and lists 51 distinct brands. Everybody and their sister is making one. iRobot doesn’t really care. Alison Dean said over and over at the Morgan Stanley Laguna Conference that iRobot is and will continue to be a premium focused company and they do not compete at the lower end of the price scale.

Consumer Product Cycle

SOURCE: IROBOT

With that in mind, let’s zero in on the premium price points and, as Dean did at the Laguna Conference, let’s separate that larger market into two separate markets. First, we’ll look at the lower end of the premium market, which we will define as the $300-$600 price range. This price point, coincidentally, is where iRobot’s two newest Roomba’s were launched. After that, we’ll look at the market priced $601 and above.

Newer Roomba Models
SOURCE: IROBOT

This lower end of the premium market shows 227 choices and again, 51 different brands. iRobot’s chart defines the explosion stage as having only one real player. The commoditization stage is defined as having 2-3 players. We won’t know if any of these other manufacturers are becoming legitimate players until the new market share numbers come out in a couple of months but we do know a lot of competitors are throwing their hats in the ring and….five of those competitors are marketing six or more products at this price point.

At the higher end of the premium range, Roomba clearly stands out. There are only 73 models and 21 distinct manufacturers listed. Significantly, Roomba models occupy six of the first seven spots on the page.

Author’s Note: The Amazon numbers listed above are large. If one does his or her own search, one would find the numbers are modestly inflated because of computer recognition error. On common thing I saw was vacuums with model numbers that fell into my searched price range were included. i.e. If there was a Samsung 550 vacuum priced at $200, the model number 550 would help it gain inclusion in the lower premium range as well as it’s correct category. In all, I would estimate these numbers would be reduced by 20% if we went through one by one.

As far as competition, we need to determine if any of the competitors have what it takes to significantly impact market share. The bears certainly believe so and judging by recent stock action, so does Mr. Market.

The biggest contender to take meaningful market share is Shark Ninja but there are others as well. Shark Ninja is already a trusted brand name and has a history of entering markets in an aggressive fashion. Shark Ninja has poached four high-level iRobot employees, including Patty Cho, Senior Director of Brand Marketing. Samsung (OTC: OTC:SSNLF) and Neato Robotics appear to be taking up more shelf space in retail stores and Ecovacs is the market leader in China and has increased its market share in Asia from non-existent to 26% in just three years.

Market Share in Asia-End of 2013

Other evidence Roomba may no longer be the only meaningful game in town:

Gross margins have declined from 52% to 48% this year. iRobot has had a tough time cracking the code in China. Some reports indicate iRobot is offering more discounts than in the past. Shark-Ion was on the cover of Kohl’s cyber Monday advertising flyer. The highest rated robotic vacuum on Amazon is a Minsu. The highest rated premium vacuum on Amazon is a bObsweep.

What’s Coming Up?

The obvious thing to mention here is that we are in the midst of the holiday shopping season. The second thing to mention is that earnings will be reported in the second week of February. At first glance, it seems odd that the Q4 estimates are well below that of Q3. However, we do know that gross margin percent is expected to be roughly 500 basis points lower than Q3, primarily due to the impact of the Robopolis acquisition. Regardless, the company has a history of underpromising and overdelivering so it would be reasonable to expect iRobot’s earnings to at least come in at the high end of guidance, which is $2.00 per share. I would expect them to be a little higher.

New Products

The whole conversation will change if iRobot comes up with a second meaningful revenue source. In the past couple years, the Looj was a failure and I think we can say the same about the Mirra Family of pool cleaners. The Braava family contributes a modest 10% of revenue but appears to be on a slight decline already so iRobot remains a Roomba story.

There is also talk about smart home but no real specifics as to how and when that will be monetized. Alison Dean says we are in “early days” and really in an exploration phase. Dean indicated that the next new product to market will likely be a robotic lawnmower.

“We’ve publicly disclosed we are working on a robotic lawnmower, so that’s the next physical product we think is important to our future.”

Since none of us know the timing or how much a robotic mower would move the needle, we need to, by and large, leave it out of our analysis but if it was to become a meaningful revenue source, the bear case would be close to extinction.

Conclusion

While everyone expects the robotic vacuum cleaner market to grow, expectations vary wildly with regard to just how pronounced future growth will be and how much of that growth iRobot will claim. On one extreme, Spruce Point Capital calls the company a “one trick pony” with a stagnant product. On the other extreme, iRobot CFO Alison Dean talks about 300% market growth in the relative near future and likens robotic vacuums to the microwave, noting that there are microwaves in almost every house and apartment today. Sandler Research, Technovia, and others are somewhere in between.

Since I would hardly call the robotic vacuum cleaner market stagnant and I have a hard time seeing it becoming as prevalent as the microwave, I am going to use the numbers in between. In order to go further with projections, we also have to decide what PE ratio the company deserves when the robotic vacuum market matures and what margins we can expect.

Starting with market growth, if we take the top end of revenue estimates and multiply by .898, we get projected Roomba revenue of $790,240,000 for 2107. If we give iRobot 63% market share this year, the overall robotic vacuum market would be $1.254 billion. If that market grows by 15.3% until 2022, the robotic vacuum market would become a $2.556 billion industry. At this point, and I may get crucified on the message boards because of this, I am going to apply a 45% global market share to iRobot, which would give Roomba a 2022 revenue number of $1.15 billion.

I am going to leave the valuation as is for two reasons. The current PE of 32 feels a little high but when you back out the net cash, the PE becomes closer to 27. You’ll notice in the chart of iRobot’s self-identified peers below, six have valuations lower than that(Fitbit’s (NASDAQ: FIT) numbers are buried) and four are higher. I also am holding margins firm even though my sense is there will be a little margin contraction with increased competition.

Chart
GPRO PE Ratio (NYSE:TTM) data by YCharts

When the dust settles, using those numbers, the results have iRobot achieving a 5.5% compound annual growth rate for the next five year. As a value investor, I will stay away because 5.5% is a modest gain and there is considerable uncertainty involved. However, if you are a growth investor who is convinced the robotic vacuum market will grow faster, iRobot will continue to command above 55% market share, or another product will generate meaningful revenue, Robot stock should be on your radar.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

About this article:ExpandAuthor payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500.Tagged: Investing Ideas, Long Ideas, Consumer Goods, AppliancesWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Best Casino Stocks To Invest In 2018

This article is reprinted by permission from NextAvenue.org.

1. Margaritaville

Jimmy Buffett sure knows how to make the most of a catchy tune and a party vibe. Somehow the 70-year-old singer-songwriter has turned wasting away again in Margaritaville into an aspirational goal. True, nibblin on sponge cake, watchin the sun bake does sound pretty nice (especially on a cold gray day in March). That laid-back sensibility is what attracts visitors to his sprawling collection of Margaritaville restaurants, casinos, hotels and resorts around the globe. And now theres another option for folks who cant get enough of the Margaritaville state of mind he peddles. Buffett has announced that hes opening a string of Margaritaville retirement communities in 2017. Which got us thinking: Which other songs could be spun into successful themed retirement communities? Quite a few, it turns out.

Best Casino Stocks To Invest In 2018: Tata Motors Ltd(TTM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    I’ve been watching Tata Motors Ltd. (TTM) over the past few years with increasing interest. As India’s largest carmaker, it stands to benefit from the tenfold projected growth in the middle class in both India and China over the next decade.

Best Casino Stocks To Invest In 2018: TNR Gold Corp. (TRRXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    ILC is fully funded to at least the end of 2017. They have reasonable insider ownership (Chairman/CEO/President Kirill Klip owns 9.98%), partner ownership (Ganfeng 19%), plus TNR Gold (OTC:TRRXF) with 17.1% are the top 3 shareholders.

Best Casino Stocks To Invest In 2018: Digital Realty Trust Inc.(DLR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Last year was brutal for hedge fund investors — but you wouldn’t know it from the fund managers’ paychecks: Link

    ECONOMIC DATA
    The MBA’s index of mortgage application activity for the latest week is schedule for release at 7:00 a.m. ET.
    The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET.
    ANALYST RATINGS
    Jefferies Upgraded ConocoPhillips (NYSE: COP) from Hold to Buy
    JPMorgan Upgraded Clovis Oncology (NASDAQ: CLVS) From Neutral to Overweight
    Morgan Stanley Upgrades TJX Companies (NYSE: TJX) From Equal-Weight to Overweight
    Macquarie Downgraded Disney (NYSE: DIS) from Outperform to Neutral
    Deutsche Bank Downgraded AvalonBay (NYSE: AVB) from Buy to Hold
    Wells Fargo Downgrades Digital Realty Trust (NYSE: DLR) From Outperform To Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    DuPont Fabros Technology, Inc. (NYSE: DFT) shares shot up 10 percent to $61.07. Digital Realty Trust, Inc. (NYSE: DLR) announced plans to merge with DuPont Fabros.

Best Casino Stocks To Invest In 2018: Helix Energy Solutions Group, Inc.(HLX)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, energy shares gained by 2.70 percent. Meanwhile, top gainers in the sector included Denbury Resources Inc. (NYSE: DNR), up 14 percent, and Helix Energy Solutions Group Inc (NYSE: HLX), up 16 percent.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Lisa Levin]

    Energy shares climbed by 1.10 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), and SunPower Corporation (NASDAQ: SPWR).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), SM Energy Co (NYSE: SM), and Ecopetrol SA (ADR) (NYSE: EC).

Best Casino Stocks To Invest In 2018: Match Group, Inc.(MTCH)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    In its first full year as a publicly traded company, online dating conglomerateMatch Group (NASDAQ:MTCH) surged past expectations, climbing 26%.

    A number of factors led to its standout performance, including blockbuster growth from Tinder, strong operating leverage, and consistently beaten earnings estimates. Let’s take a closer look at how things played out in 2016.

  • [By Peter Graham]

    Small cap dating site stock Match Group Inc (NASDAQ: MTCH), which was spun off from media and Internet stock IAC/InterActiveCorp (NASDAQ: IAC) and is a peer or remaining dating stock Spark Networks Inc (NYSEMKT: LOV), is the eight most shorted stock on theNASDAQ with short interest of 43.96% according to Highshortnterest.com.